Cisplatin

Overview

Cisplatin (CDDP) is an antineoplastic chemotherapy agent by cross-linking with DNA and causing DNA damage in cancer cells. Cisplatin activates ferroptosis and induces autophagy .

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Lung Cancer | Products > Disease Areas > Respiratory Cancer | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Non-Small Cell Lung Cancer | Products > Disease Areas > Lung Adenocarcinoma | Products > Disease Areas > Lung Squamous Cell Carcinoma | Products > Disease Areas > Large Cell Lung Carcinoma | Products > Disease Areas > Triple-Negative Breast Cancer | Products > Disease Areas > Metastatic Breast Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Pyroptosis | Products > Signaling Pathways > Lipoxygenase | Products > Signaling Pathways > DNA Alkylator/Crosslinker | Products > Signaling Pathways > Ferroptosis | Products > Signaling Pathways > Autophagy

Product Information

• Catalog No.: HY-17394
• CAS No.: 15663-27-1
• Molecular Formula: Pt(NH3)2Cl2
• Molecular Weight: 300.05
• Purity: 99.30%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: 1 mg/mL (3.33 mM); Clear solution; Need ultrasonic
• Availability: In-stock

Source

Original product source